Do you want to read an article? Please log in or register.
Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
Lung, Respiratory and Thoracic Cancer